Wellington Management Group
ITCI

Wellington Management Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Wellington Management Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-190,370
Closed -$25.1M – 2078
2025
Q1 		$25.1M Sell
190,370
-843,373
-82% -$105M ﹤0.01% 892
2024
Q4 		$86.3M Buy
1,033,743
+16,096
+2% +$1.32M 0.02% 568
2024
Q3 		$74.5M Sell
1,017,647
-235,257
-19% -$17.7M 0.01% 606
2024
Q2 		$85.8M Sell
1,252,904
-408,966
-25% -$28.4M 0.02% 573
2024
Q1 		$115M Sell
1,661,870
-101,605
-6% -$6.98M 0.02% 518
2023
Q4 		$126M Sell
1,763,475
-52,479
-3% -$3.02M 0.02% 511
2023
Q3 		$94.6M Buy
1,815,954
+114,370
+7% +$6.66M 0.02% 544
2023
Q2 		$108M Sell
1,701,584
-3,323,199
-66% -$207M 0.02% 531
2023
Q1 		$272M Sell
5,024,783
-384,902
-7% -$18.6M 0.05% 320
2022
Q4 		$286M Buy
5,409,685
+250,935
+5% +$12.6M 0.06% 313
2022
Q3 		$240M Buy
5,158,750
+695,392
+16% +$36.3M 0.05% 327
2022
Q2 		$255M Buy
4,463,358
+402,198
+10% +$22.8M 0.05% 317
2022
Q1 		$249M Buy
+4,061,160
New +$211M 0.04% 364

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wellington Management Group's ITCI Position: Q2 2025 in Review

Wellington Management Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 190,370 shares — an estimated $25.1M sold.

Wellington Management Group first reported a position in ITCI in Q1 2022 and held it in 13 quarters. The position peaked at $286M in Q4 2022. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Wellington Management Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Wellington Management Group sold 190,370 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $25.1M.
  • Wellington Management Group first reported a position in Intra-Cellular Therapies Inc. in Q1 2022 and held it in 13 quarters.
  • Wellington Management Group's Intra-Cellular Therapies Inc. position peaked at $286M in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.